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Current meta-omics developments provide a portal into the functional potential and activity
of the intestinal microbiota. The comparative and functional meta-omics approaches have
made it possible to get a molecular snap shot of microbial function at a certain time and
place. To this end, metagenomics is a DNA-based approach, metatranscriptomics studies
the total transcribed RNA, metaproteomics focuses on protein levels and metabolomics
describes metabolic profiles. Notably, the metagenomic toolbox is rapidly expanding
and has been instrumental in the generation of draft genome sequences of over 1000
human associated microorganisms as well as an astonishing 3.3 million unique microbial
genes derived from the intestinal tract of over 100 European adults. Remarkably, it
appeared that there are at least 3 clusters of co-occurring microbial species, termed
enterotypes, that characterize the intestinal microbiota throughout various continents.
The human intestinal microbial metagenome further revealed unique functions carried out
in the intestinal environment and provided the basis for newly discovered mechanisms
for signaling, vitamin production and glycan, amino-acid and xenobiotic metabolism. The
activity and composition of the microbiota is affected by genetic background, age, diet,
and health status of the host. In its turn the microbiota composition and activity influence
host metabolism and disease development. Exemplified by the differences in microbiota
composition and activity between breast- as compared to formula-fed babies, healthy and
malnourished infants, elderly and centenarians as compared to youngsters, humans that
are either lean or obese and healthy or suffering of inflammatory bowel diseases (IBD).
In this review we will focus on our current understanding of the functionality of the
human intestinal microbiota based on all available metagenome, metatranscriptome, and
metaproteome results.
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INTRODUCTION
The human intestinal microbiota is known to play a key role
in several metabolic, nutritional, physiological, and immuno-
logical processes, and recent years have seen a rapid develop-
ment in the techniques for studying this previously overlooked
organ (O’Hara and Shanahan, 2006). The human microbiota is
established after birth and starts out as a dynamic ecosystem,
dominated by bifidobacteria, that stabilizes during the first 2–3
years (Koenig et al., 2011; Scholtens et al., 2012). During life the
microbial composition increases in both diversity and richness
(Scholtens et al., 2012) (Figure 1) and reaches highest com-
plexity in the human adult, with several hundred species-level
phylotypes dominated by the phyla Bacteroidetes and Firmicutes
(Rajilic-Stojanovic et al., 2009). Each human individual reaches a
homeostatic climax composition, which likely remains relatively
stable during most of a healthy adult’s life. Although the indi-
vidual microbial composition has an “individual core” that varies
at the bacterial phylotype level and depends on the depth of the
analysis (Zoetendal et al., 2008; Jalanka-Tuovinen et al., 2011),
the overall phylogenetic profile can be categorized into a limited
number of well-balanced host-microbial symbiotic states, the
so-called enterotypes (Arumugam et al., 2011). At the late stages
of life the microbiota composition becomes again less diverse and
more dynamic, characterized by a higher Bacteroides to Firmicutes
ratio, increase in Proteobacteria and decrease in Bifidobacterium
(Biagi et al., 2010) (Figure 1).
The establishment of the bacterial ecosystem in early life is sug-
gested to play a role in the microbial composition and disease
susceptibility throughout life (Scholtens et al., 2012). A differ-
ent microbiota composition is associated with chronic intestinal
disorders and the severity of perturbation during disease and
after antibiotic use (Sekirov et al., 2010). Diet is another impor-
tant factor in microbiota composition development. Early in life
there is already an impact of the diet on the microbiome: the
microbiota of breast-fed and formula-fed infants was found to
differ significantly in both composition and diversity. Breast-fed
babies contain a microbiota that is more heterogeneous than that
of formula-fed babies and contain a higher taxonomic diversity
(Schwartz et al., 2012) (Figure 1). In addition, food habits can
influence microbiota composition, and malnutrition results in
lower abundance of Bacteroidetes that are shown to be specialized
in breaking down the carbohydrates in energy rich western diet
Frontiers in Cellular and Infection Microbiology www.frontiersin.org August 2012 | Volume 2 | Article 104 | 1
CELLULAR AND INFECTION MICROBIOLOGY
Ottman et al. Functionality of the human microbiota
healthy 
obese 
65 to 80 years  
>100 years 
healthy 
antibiotic 
 treatment 
malnutrition breast-fed 
formula-fed 
solid food 
Baby Toddler Adult Elderly 
16S 
16S 
16S 
DNA 16S 
DNA 
16S 
16S 
DNA 
16S 
DNA 
16S 
16S 
16S 
Unborn
Firmicutes
Bacteroidetes
Actinobacteria
Proteobacteria
others
FIGURE 1 | Humanmicrobiota: onset and shaping through life stages and
perturbations. The graph provides a global overview of the relative abundance
of key phyla of the human microbiota composition in different stages of life.
Measured by either 16S RNA or metagenomic approaches (DNA). Data
arriving from: Babies breast- and formula-fed (Schwartz et al., 2012), baby solid
food (Koenig et al., 2011), toddler antibiotic treatment (Koenig et al., 2011),
toddler healthy or malnourished (Monira et al., 2011), adult, elderly, and
centenarian healthy (Biagi et al., 2010), and adult obese (Zhang et al., 2009).
foods. Diet-related diseases such as allergies and obesity are also
characterized by microbiota changes. Obesity is characterized by
a typical Firmicutes to Bacteroides ratio. Energy harvest potential
and short chain fatty acids (SCFA) are determined by the micro-
biota composition and have a direct effect on the host epithelial
cell energy availability. A microbiota stimulated with probiotic
microbes can even decrease the incidence of infant diarrhea and
atopic eczema due to host immune stimulation (Niers et al., 2009;
Sjogren et al., 2009).
Numerous meta-omics approaches have vastly increased the
knowledge available on the genome, activity and functionality of
the complex ecosystem residing in the human gut. By far the most
commonly applied technique is metagenomics, which is based on
direct isolation and, in most cases, sequencing of the complete
genetic material obtained from an environmental sample, such as
the intestine. However, one of the biggest drawbacks of this tech-
nique is its inability to display the actual metabolic activity due to
the fact that it detects both expressed and non-expressed genes.
In addition, it may generate information from dead cells as it is
known that more than half of the cells in fecal samples are non-
viable or heavily damaged (Ben-Amor et al., 2005). Instead of
focusing on microbiota composition the purpose of this review is
to combine the available knowledge on microbial genomics with
reports on the functional metagenomics, i.e., transcriptomics and
proteomics approaches. This combination is expected to provide
a refined understanding of the role of the microbiota and its
capabilities in regulating human health.
ROLE OF THE MICROBIOTA IN EARLY AND LATE LIFE
EARLY LIFE
During natural birth, a newborn is exposed to the environmental,
mainly maternal, microbiota which commences the acquisition
of what we assume is a normal microbiota. The mode of deliv-
ery strongly affects the composition of the microbiota. In the case
of caesarean delivery (C-section), other environmental bacteria
form the basis for the microbiota instead of vaginal and faecal
bacteria from the mother, reportedly resulting in a substantial
reduction of bifidobacteria (Biasucci et al., 2008). In a compari-
son of the microbiota of babies delivered either vaginally or via
C-section, it was shown that the newborns harbored undiffer-
entiated bacterial communities across skin, oral, nasopharyngeal,
and gut habitats regardless of delivery mode, and that the micro-
biota of C-section babies was similar to the skin communities of
the mothers whereas vaginally delivered infants acquired bacterial
communities resembling the vaginal microbiota of their mothers
(Dominguez-Bello et al., 2010). Other factors influencing the
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microbiota are the type of infant feeding, gestational age, infant
hospitalization, and antibiotic use by the infant. The microbiota
of breast-fed infants is dominated by bifidobacteria whereas the
counts of Escherichia coli, Clostridium difficile, Bacteroides frag-
ilis and lactobacilli are higher in exclusively formula-fed infants
(Penders et al., 2006).
The composition of the intestinal microbiota plays an impor-
tant role in immune system development, and it is possible that
childhood allergies are related to differences in the microbiota
(Sjogren et al., 2009). The intestinal defense of the preterm infant
is rather immature and exaggerates inflammatory responses that
can be evoked by both commensal and pathogenic bacteria
(Nanthakumar et al., 2000). Thus, the first microbes colonizing
the intestinal tract hold a pivotal role. Once the core microbiota
has developed, it stabilizes and is expected to become less sensitive
to modification. The question is at what age does the microbiota
become adult-like and recent data with large cohorts of babies in
various parts of the world indicate that this is at ages after at least
3 years (Yatsunenko et al., 2012).
The succession of the microbial ecosystem in the intestinal
tract of newborns is a complicated process, which is not yet
fully understood. The increasing diversity of the microbiota is
believed to have an effect on the functional gene content over
time. Several studies have provided insight in the infant gut
community structure and its perturbations during early develop-
ment and highlighted the impact of weaning (Favier et al., 2002,
2003). Moreover, a recent 2.5-year case study was reported, where
sixty fecal samples were collected from a healthy infant (Koenig
et al., 2011) (Figure 1). The results of this study showed a grad-
ual increase in the phylogenetic diversity of the microbiome over
time. Life events such as changes in diet, illnesses, and antibiotic
treatments were associated with large shifts in the abundances of
major groups in this single infant. Assignment of gene functions
to the metagenomic data from this study revealed an enrichment
of carbohydrate-metabolizing genes involved in lactate utiliza-
tion from the very beginning of life. Interestingly, during an
exclusive breast-milk diet, genes facilitating the breakdown of
plant-derived polysaccharides were already present, suggesting
that the microbiota is metabolically prepared to receive simple
plant-derived foods. This is consistent with other observations
that showed high similarity in the proportions of Clusters of
Orthologous Groups (COG) encoding proteins specialized for
the transport and metabolism of plant polysaccharides or COGs
encoding proteins transporting and metabolizing human milk
oligosaccharides (HMO) between infant and maternal micro-
biota samples (Vaishampayan et al., 2010) (Table 1). Baby gut
microbiomes are also enriched in functions involved in using
glycans represented in breast milk and the intestinal mucosa,
even more so in the microbiomes of Amerindian and Malawian
babies compared with US babies, possibly reflecting differ-
ences in the glycan content of breast milk (Yatsunenko et al.,
2012).
Recently it has been shown that the use of specific human
milk-derived glycans such as HMO utilization is not exclusive
to certain well-known infant colonizers, such as Bifidobacterium
species, since members of the genus Bacteroides can also use
milk glycans as a sole carbon and energy source (Marcobal
et al., 2010). Moreover, it has been shown that Bacteroides
thetaiotaomicron responds to common structural motifs found
in oligosaccharides from mother’s milk and intestinal mucin
glycans, suggesting that HMOs may mimic mucus glycans to
attract mucin-adapted residentmutualists to an infantmicrobiota
(Marcobal et al., 2011). However, specific HMO components
select for HMO-adapted species such as Bifidobacterium longum
subsp. infantis, and provide a selective advantage to this species
in vivo when biassociated with B. thetaiotaomicron in the gnoto-
biotic mouse gut. The complex oligosaccharide mixture within
HMOs thus attracts both mutualistic mucus-adapted species and
Table 1 | Percentages of COG categories expressed in the gut microbiota.
Population Sample
size (n)
COG categories (percentage of all genes) Reference
C E G L M J O
mother 1m 1 5.0 6.0 11.0 10.0 8.5 3.0 3.0 Vaishampayan et al., 2010
mother 11m 1 6.0 10.0 12.0 5.5 6.0 5.0 2.5 ”
infant 1m 1 7.0 7.5 11.5 6.0 6.0 4.5 4.0 ”
infant 11m 1 4.0 11.0 12.0 7.5 6.0 5.0 3.0 ”
female twin paira 2 14.0 n/a 16.0 n/a n/a 19.0 12.0 Verberkmoes et al., 2009
healthy volunteers 10 6.0–13.0 3.5–7.0 9.5–22.0 3.5–11.0 1.5–8.0 9.0–15.0 2.5–14.0 Gosalbes et al., 2011
female cotwin (TS28)b 1 8.0 7.0 8.0 6.0 6.0 9.0 6.0 Turnbaugh et al., 2010
female cotwin (TS29)b 1 8.0 6.0 9.0 5.0 5.0 10.0 7.0 ”
female cotwin (TS28)c 1 5.0 6.0 8.0 9.0 6.0 7.0 5.0 ”
female cotwin (TS29)c 1 5.0 7.0 9.0 9.0 6.0 6.0 4.0 ”
COG descriptions: C, Energy production and conversion; E, Amino acid transport and metabolism; G, Carbohydrate transport and metabolism; L, DNA replication,
recombination, and repair; M, Cell envelope biogenesis, outer membrane; J, Translation, ribosomal structure, and biogenesis; O, Post-translational modification,
protein turnover, chaperones
a out of the core proteome
b out of genes with high relative expression
c out of genes with low relative expression.
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HMO-adapted bifidobacteria to the infant intestine that likely
facilitate both milk and future solid food digestion.
Little is known of the effect of diet on the composition
and in particular the activity of the developing gut microbiota.
Comparison of host epithelial cell gene expression andmicrobiota
profile between breast- and formula-fed infants demonstrated
that differences in the diet of infants can have an influence on
the host gene expression via the gut microbiota (Schwartz et al.,
2012). Virulence characteristics of the microbiota were the only
functional properties that were found to differ among these two
groups. Further analysis of the host transcriptome revealed a
subset of eleven immunity and mucosal defense-related genes
exhibiting evidence of a multivariate relationship with micro-
biome virulence characteristics. This provides additional proof
for the capability of humanmilk to promote themutualistic inter-
actions between themucosal immune system and themicrobiome
in maintaining intestinal homeostasis. Gene content analysis of
the gut microbiome of 110 individuals including both adults
and babies from Venezuela, Malawi, and the US revealed age-
related changes in the metabolism of vitamins B12 (cobalamin)
and folate (Yatsunenko et al., 2012). Genes involved in de novo
biosynthesis of folate decreased with age whereas genes encoding
most enzymes associated with cobalamin biosynthesis increased,
correlating with previous data of blood levels of these vitamins in
different age groups (Monsen et al., 2003).
The key players in the neonate gut are the bifidobacteria, which
dominate the microbial community of human milk-fed infants.
A number of studies using metagenomic approaches have also
demonstrated the importance of this genus in the developing gut
(Turroni et al., 2012; Yatsunenko et al., 2012), while at the same
time other studies have reported low abundance or even absence
of bifidobacteria (Palmer et al., 2007; Koenig et al., 2011), most
likely due to technical biases related to DNA extraction protocols
or the selected PCR primers. Genome analysis of Bifidobacterium
longum subsp. infantis revealed a nutrient-utilization strategy tar-
geting milk-derived molecules which are not of nutritional value
to the infant (Sela et al., 2008). The proteomic profile of the
organism grown on HMOs confirmed the activity of these genes
(Sela et al., 2008). This suggests B. longum subsp. infantis coe-
volved with its infant host and under the presence of human milk
compounds.
Furthermore, the type of milk, either mother’s milk or for-
mula, determines the colonization with different types of bifi-
dobacteria. Breast-fed infants contain a high abundance of
Bifidobacterium breve. In contrast, faecal samples from standard
formula-fed infants lacked detectable amounts of this B. breve
but contained B. longum. Remarkably, infants that received breast
milk and later a prebiotic formula consisting of a standard for-
mula milk containing a mixture of specific galacto- and fructo-
oligosaccharides, continued to harbor a B. breve-dominant faecal
population (Boesten et al., 2011).
Transcriptional analysis of the response of B. longum to human
milk and formula milk indicated upregulation of genes involved
in carbohydrate metabolism in breast milk, endorsing the con-
cept that the bifidogenic effect of breast milk is primarily based
on its oligosaccharides (Gonzalez et al., 2008). Moreover, the
same study found upregulation of putative genes for cell surface
type 2 glycoprotein-binding fimbriae associated with attachment
and colonization in the intestine in both breast milk and formula
milk when compared to semisynthetic medium with glucose.
Transcriptome analysis of B. breve in a mouse model also showed
differential expression of genes encoding for the production of
type IVb tight adherence pili, which are essential for efficient
in vivo murine gut colonization (O’Connell Motherway et al.,
2011).
Another study comparing the bifidobacterial transcriptome of
breast-fed infants and prebiotic-containing formula-fed infants
showed that in the beginning of the intervention breast-fed
infants had higher counts of bifidobacteria compared to the
formula-fed infants (Klaassens et al., 2009). However, during
the intervention the bacterial numbers and species diversity of
Bifidobacterium increased significantly in the formula-fed infants,
possibly on account of the galacto- and fructo-oligosaccharides
in the formula. These prebiotics have also previously been shown
to shift the bifidobacterial quantities toward those of breast-
fed infants (Knol et al., 2005). The metatranscriptome anal-
ysis in babies revealed that the most prominent functions of
the transcripts were related to carbohydrate metabolism, with
higher expression of genes encoding these functions in breast-fed
infants compared to formula-fed infants (Klaassens et al., 2009).
This included significant expression of genes involved in HMO
degradation. Moreover, the expression of genes involved in folate
production was observed in all babies indicating that intestinal
bifidobacteria produced this important vitamin involved in neu-
ral development. In the same study, a gene for bifidobacterial
transaldolase, which is a key enzyme of the non-oxidative phase
of the pentose phosphate pathway, was expressed in samples from
all infants. Bifidobacterial transaldolase was also found in the only
metaproteome study thus far to look at the infant gut micro-
biota (Klaassens et al., 2007). Production of the protein spot on
a 2D-gel corresponding to this protein was increased over time,
suggesting an increase in the numbers and activity of bifidobac-
teria in the infant’s gut. Understanding the factors relating to the
existence and host interactions of bifidobacteria and linking the
functionality of this early intestinal colonizer to specific diets and
groups of healthy or diseased individuals may eventually lead to
the possibility of guiding the development of the microbiota. This
can be achieved with pro- and prebiotic supplemented infant for-
mulas that are aimed at increasing the bacterial diversity and a
more optimal bifidobacterial community composition.
LATE LIFE
In addition to the beginning of life, the microbiota also under-
goes significant changes toward the other extremity of life, old
age. These alterations, however, are not clear-cut partially due
to the various physiological changes that the elderly go through.
These include factors such as modifications in lifestyle, nutri-
tional behavior, increase in infection rates and inflammatory
diseases, and therefore the need for more medication. All of these
issues will certainly also affect the composition and activity of the
microbiota, but the course andmechanisms behind these changes
are not yet completely understood.
The process of ageing has been demonstrated to have a nega-
tive effect on the diversity of the microbiota, but different studies
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have reported conflicting results on the age-related changes with
regard to the two major phylogenetic groups. Assessment of the
gut microbiota of the elderly with quantitative PCR revealed high
levels of Escherichia coli and Bacteroidetes as well as a significant
difference in the Firmicutes to Bacteroidetes ratio for adults (10.9)
and elderly individuals (0.6) (Mariat et al., 2009). In this study
the total bacterial counts for adults and seniors were comparable
whereas another study, employing cytosine (%G + C) profiling
and 16S rRNA gene sequencing, described a significant reduc-
tion in overall numbers of microbes in elderly subjects compared
to young adults (Makivuokko et al., 2010). They also observed
lower numbers of Firmicutes and an increase in Bacteroidetes,
with lowered amounts of known butyrate producers belonging
to Clostridium cluster XIVa.
Another study, which included young (20–40 years old),
elderly (60–80 years old) and an additional group of cente-
narian citizens (∼100 years old), clearly demonstrated that the
process of ageing coincides with decreasing microbiota diversity
(Biagi et al., 2010) (Figure 1). By using the Human Intestinal
Tract Chip (HITChip) and qPCR, they observed that the com-
position of microbiota was quite similar between the young
and the elderly groups represented by dominant portions of
Firmicutes and Bacteroidetes (95% of total bacteria). The cente-
narian group also showed a dominant portion of Firmicutes and
Bacteroidetes (93% of total bacteria). The Firmicutes/Bacteroidetes
ratios obtained for the centenarians, elderly and young adults
were 3.6, 5.1, and 3.9, respectively. However, there was a signif-
icant decrease in the Firmicutes subgroup Clostridium cluster XIV
and an increase in Bacilli in the centenarian group. Furthermore,
there was a significant increase in several facultative anaerobes,
members of the Proteobacteria phylum, many of which constitute
opportunistic pathogens. This rearrangement of the microbiota
does not seem to be in favor of the aging subjects that showed an
increased level of circulating inflammatory cytokines. These were
inversely associated with bacteria belonging to Clostridium cluster
XIV and Clostridium cluster IV that include the main butyrate-
producers in the gut. Butyrate has been associated with a range of
health effects from anti-inflammatory properties to enhancement
of intestinal barrier function (Macfarlane and Macfarlane, 2011).
Recently, pyrosequencing of tagged PCR-amplified 16S rRNA
genes was applied to characterize the fecal microbiota of 161
seniors aged 65 years and older in the ELDERMET consortium
(Claesson et al., 2011). In this extensive study the elderly micro-
biota was observed to be dominated by the phylum Bacteroidetes
(57%) compared with Firmicutes (40%). However, the propor-
tions of the major phyla showed extraordinary variation between
individuals, with the proportion of Bacteroidetes ranging from
3 to 92% and Firmicutes from 7 to 94%. In addition to the general
composition, also the core microbiota of the elderly differed sub-
stantially with that of young adults, characterized by a shift to a
moreClostridium cluster IV-dominated community in the elderly.
The microbiota of the elderly showed temporal stability for the
majority of subjects as revealed by analysis of 3-month follow-up
samples.
These studies indicate that there undoubtedly are fluctua-
tions in the elderly microbiota, but both the threshold for an
“aged” microbiota and the trends for these changes seem to be
highly variable. Some of these differences may be explained by
country-specific dietary habits, as the most recent studies used
separate cohorts from two different European countries, Italy
(Biagi et al., 2010) and Ireland (Claesson et al., 2011). The liv-
ing environments of elderly people are highly dependent on
their health status, with healthier seniors living independently
and subjects with medical issues often living in nursing homes.
These factors can also influence the aging gut microbiota. Follow-
up studies assessing the function of the elderly gut microbiota
by functional metagenomic techniques already applied for the
infant and adult microbiota will shed more light on these issues
and reveal prospects for possible dietary interventions aimed at
improving the health of the elderly.
MICROBIOTA ACTIVITY IN RESPONSE TO DIET
Host dietary habits appear to affect gut microbiota composi-
tion, but the actual association between different diets and the
microbial community composition as well as the underlying
causes for this are still unclear. Although there was no clear
environmental or genetic explanation found for the initial
clustering of the enterotypes (Arumugam et al., 2011), these
were found to be strongly associated with long-term diets,
with protein and animal fat correlating with the enterotype
characterized by high levels of Bacteroidetes, and carbohydrates
with the Prevotella enterotype (Wu et al., 2011). Differences in
microbiota composition as a result of diverging dietary habits
was also shown in a comparison of the microbiota of European
children, who consumed a diet high in animal protein, sugar,
starch and fat and low in fiber, and children from Burkina Faso,
where the predominantly vegetarian diet consists mainly of
carbohydrates, fiber and non-animal protein (De Filippo et al.,
2010). The European microbiome was enriched with Firmicutes
and Proteobacteria, whereas Actinobacteria and Bacteroidetes
were more represented in the African children. Interestingly,
Xylanibacter and Prevotella were only present in the children from
Burkina Faso, leading the authors to hypothesize that members
of these genera could improve the ability to extract calories
from indigestible polysaccharides commonly consumed in rural
Africa indicating a coevolution of the microbial community
with the polysaccharide-rich diet. Malnourished children from
poor socio-economic status families in Bangladesh were found
to have lower diversity of gut microbiota compared to healthy
children from moderate to high income families in the same
region, characterized by lower relative abundance of Bacteroidetes
and a dominance of Proteobacteria (Monira et al., 2011). The
authors suggest that the low presence of Bacteroidetes, which
are known to digest complex dietary material and thus improve
energy extraction from various foods, and the higher presence
of potentially pathogenic Proteobacteria might contribute to
explaining the poor health of the malnourished children.
In ametagenome study, short-term dietary intervention (high-
fat/low-fiber or low-fat/high-fiber diets) lead to rapid changes
in the microbiome composition but was not sufficient to shift
individuals between the two enterotypes described in the same
study (Wu et al., 2011). Few functional gene categories, includ-
ing bacterial secretion system, protein export, and lipoic acid
metabolism, differentiated between the two test diets suggesting
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a shift in selected bacterial functions in response to the dietary
changes. Microbiome analysis of subjects on a diet rich in pro-
tein, typically consumed in the US, showed enrichment of mul-
tiple Enzyme Commission (EC) groups when compared with
Malawian and Amerindian subjects consuming a diet high in car-
bohydrates (Yatsunenko et al., 2012). These included degradation
of glutamine and other amino acids, catabolism of simple sugars,
vitamin biosynthesis, and bile salt metabolism. Degradation of
glutamine has earlier been found to be overrepresented in carniv-
orous mammalianmicrobiomes, while glutamate synthase, which
was enriched inMalawian/Amerindianmicrobiomes, was present
in higher proportions in herbivorous mammalian microbiomes
(Muegge et al., 2011).
Several metatranscriptome and metaproteome studies
describing the human intestinal microbiota have confirmed
the importance of bacterial functions related to carbohydrate
metabolism in the colon. Enrichment of these genes has earlier
been shown in metagenomic studies of the human gut (Gill
et al., 2006; Kurokawa et al., 2007; Turnbaugh et al., 2009a).
Metatranscriptome analysis of fecal samples from two healthy
volunteers found thatmost expressed genes (26% of all sequenced
and annotated transcripts) were involved in the metabolism of
carbohydrate (Booijink et al., 2010). Recently the majority of
bifidobacterial transcripts within the fecal community of adults
were also reported to be involved in metabolism of carbohydrates
of plant origin (Klaassens et al., 2011).
Similar results were seen in a transcriptional analysis of
fecal samples from a monozygotic, obese twin pair (Turnbaugh
et al., 2010) (Table 1), and metatranscriptomics analysis of fecal
samples from ten healthy volunteers (Gosalbes et al., 2011)
(Table 1). Metatranscriptomic data from the less studied small
intestinal microbiota showed enrichment in sugar phosphotrans-
ferase (PTS) and other carbohydrate transport systems, as well
as energy- and central metabolic, and amino acid conversion
pathways as compared with the metagenome (Zoetendal et al.,
2012). This suggests rapid uptake and fermentation of available
simple sugars by the small intestinal microbiota, compared to
the degradation of more complex carbohydrates by the bacte-
ria in the colon. The importance of carbohydrate metabolism is
also evident from the enormous amount of carbohydrate-active
enzymes (CAZymes) present in the gut microbiome. By apply-
ing amulti-step functional screening procedure of a metagenomic
library from the feces of volunteer following a fiber-rich diet,
73 CAZymes from 35 different families were recently discovered
(Tasse et al., 2010).
Shotgun metaproteomics approach used to identify micro-
bial proteins in fecal samples from a female twin pair iden-
tified several COG categories more highly represented in the
microbial metaproteome compared to the average metagenome
(Verberkmoes et al., 2009) (Table 1). A high proportion of
the proteins that were equally abundant in both samples were
from common gut bacteria, such as Bacteroides, Bifidobacterium,
and Clostridium. These included proteins involved in trans-
lation, carbohydrate metabolism and energy production. In
another study, two human fecal samples were analyzed and the
functions of the identified proteins were predicted (Rooijers
et al., 2011). The most abundantly present COGs were involved
in translation, energy production, and conversion as well as
carbohydrate transport and metabolism, which supports the
findings of studies linking the microbiota with carbohydrate
metabolism (Kovatcheva-Datchary et al., 2009). The study also
pointed out the abundance of Akkermansia muciniphila, the only
intestinal member of the Verrucomicrobia, within the microbiota
and showed that most of the proteins produced by these bac-
teria are involved in carbohydrate transport and metabolism as
well as amino acid transport and metabolism. This is in line
with observation that A. muciniphila can use mucin as the sole
carbon and nitrogen source (Derrien et al., 2008). The fecal
samples were also subject to metagenome sequencing and the
phylogenetic diversity was determined with two approaches, 16S
rRNA sequence analysis of the metagenomic data sets and an
abundance analysis of the metagenomic sequences using a syn-
thetic metagenome as reference set. The results showed that
Bacteroidetes, Firmicutes, Actinobacteria, Verrucomicrobia, and
Proteobacteria were the dominant groups in the microbiota of the
study subjects.
These results were further confirmed by analysing the gut
metaproteome of three healthy subjects over a period of 6–12
months (Kolmeder et al., 2012). In this study, proteins involved
in carbohydrate transport and metabolism accounted for over
10% of the detected proteins, forming a part of the core metapro-
teome found in all the test subjects. The glycolysis pathway,
in particular, was noticeable with several related enzymes iden-
tified. After assigning the spectral hits for each COG func-
tional category per phylum, it was apparent that Firmicutes
and Actinobacteria were responsible for the active carbohydrate
metabolism, while Bacteroidetes showed more mixed functions.
Both Firmicutes and Bacteroidetes were found to have an active
carbohydrate metabolism on a transcriptional level in an ear-
lier report (Gosalbes et al., 2011). Furthermore, Kolmeder et al.
(2012) observed that the majority of the identified actinobacte-
rial peptides were predicted to be involved in sugar metabolism.
The importance of carbohydrate metabolism has been shown also
previously for the core genome of bifidobacteria (Bottacini et al.,
2010). Temporal analysis showed that the metaproteome is stable
over time, as is the microbial composition of the gut, suggesting
that homeostasis in function and composition of the intestinal
microbiota are tightly linked (Kolmeder et al., 2012).
Recently, a metatranscriptomics approach with RNAseq has
been applied to investigate the effect of a fermented milk product
(FMP) containing several probiotics on the gut microbiome of
gnotobiotic mice colonized with a model human gut microbiota
and monozygotic twins (McNulty et al., 2011). There were no or
minimal changes observed in the bacterial species composition in
mice and humans after consumption of FMP. Still, transcriptional
analysis revealed significant changes in numerous metabolic path-
ways, especially in carbohydrate metabolism, in both mice and
human subjects. The question, however, is whether this reflects
a functional difference in the colon or is a result of technical or
biological effects such as variations in the transit time of the fecal
material used for this analysis.
Metagenomic approaches combined with studies using gno-
tobiotic animals colonized with only a few known microor-
ganisms or even the entire human fecal microbiota provide a
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powerful tool for examining the relationship between the host
and the functionality of the microbial community under con-
trolled conditions. A study of humanized gnotobiotic mice trans-
planted with either fresh or frozen adult human fecal microbial
communities into germ-free C57BL/6J mice revealed a stable and
heritable colonization which enabled a diet intervention, where
the mice were switched from a low-fat, plant polysaccharide to
a high-fat, high-sugar diet (Turnbaugh et al., 2009b). This diet
change induced a structural shift in the microbiota within one
day and presented an enrichment for various KEGG pathways
involved in nutrient processing compared to the control diet.
Metatranscriptome analysis of rRNA-depleted RNA isolated from
the ceca of the humanized mice demonstrated a clear differ-
ence in the gene expression of the mice on the Western diet
compared to the control group, with upregulation of clusters
containing Clostridium innocuum strain SB23 genes encoding
Western diet-associated transcripts (pyruvate formate-lyase, PTS,
phosphoglycerate kinase) and Firmicutes gene clusters encoding
ABC-type sugar transport systems.
A shift in the microbial community was also seen after
switching both wild-type and RELMβ-deficient mice to a high-
fat diet, indicating that the diet itself was responsible for the
detected changes independent of obesity (Hildebrandt et al.,
2009). RELMβ is a colonic goblet cell-specific gene, whose expres-
sion is dependent on the presence of the gut microbiome. After
the dietary switch the amounts of Proteobacteria, Firmicutes, and
Actinobacteria increased whereas Bacteriodetes decreased, as mea-
sured from fecal samples. Analysis of gene functions revealed a
decrease in the number of metabolic genes under the high-fat
condition, possibly as a result of nutrient deficiency. However, as
also noted by Turnbaugh et al. (2009b), a group of genes for ABC-
transporters increased in abundance, indicating adaptation to the
high-fat diet by enhancing nutrient intake in an environment with
limited substrate availability.
Mice colonized with 10 sequenced human gut bacteria, and
fed with a series of refined diets showed that casein concentra-
tion was highly correlated with the yield of total DNA per fecal
pellet in all 17 test diets (Faith et al., 2011). The abundance of
all of the ten species was significantly associated with casein, with
seven of them positively correlated with casein concentration and
three negatively correlated. None of the diets caused significant
changes in the gene expression of the bacterial species, analyzed
by RNA-sequencing, but high expression of genes predicted to be
involved in pathways using amino acids as substrates for nitro-
gen, as energy and/or carbon sources were found for the species
positively correlated with casein.
In conclusion, the studies to date endorse the concept that the
intestinal microbiota thrives on using polysaccharides and pep-
tides, which are indigestible to human (Guarner and Malagelada,
2003). The metagenomic data are confirmed on a functional
level by the metatranscriptomics and metaproteomics data. The
composition of the microbiota in the colon is dominated by
Firmicutes that appear to be active in carbohydrate metabolism
whereas Bacteroidetes show activity in a number of functions like
energy production and conversion as well as amino acid transport
and metabolism, in addition to carbohydrate metabolism. The
complex polysaccharides are degraded by a specialized microbial
community and the released oligosaccharides can in turn be used
by other commensal bacteria. In this manner, diet is has a crucial
influence on the intestinal microbial activity.
MICROBIAL IMBALANCES AND DISEASE
INFLAMMATORY BOWEL DISEASES
The gut microbiota has been connected to several diseases, with
obesity and inflammatory bowel diseases (IBD) representing the
most studied disorders to date. Most research about potential dif-
ferences of microbiota related to different disease states has so
far focused on describing the composition and diversity of the
microbiome in patients compared to healthy subjects, and conse-
quently revealing interesting associations between them. In order
to get a better understanding of the underlyingmechanisms of the
relationship between the microbial communities and specific dis-
orders, functional microbiomic approaches need to be employed.
Despite exhaustive research efforts, the etiology and pathogen-
esis of IBD, including Crohn’s disease (CD) and ulcerative colitis
(UC) have stayed unclear. The causes of these intestinal diseases
are most likely linked with both human gene- and microbiome-
associated factors (Pflughoeft and Versalovic, 2012). CD and UC
patients seem to harbor separate microbial communities both
from each other and healthy subjects, and also have lower bacte-
rial diversity compared to healthy people (Manichanh et al., 2006;
Dicksved et al., 2008; Qin et al., 2010). Several bacterial groups
have been implied to be either increased or decreased in associa-
tion with IBD. However, it is not clear whether this dysbiosis is the
reason for the inflammation in IBD, or simply something caused
by the disturbed environment in the GI tract.
Metagenomic studies and microarray analyses have demon-
strated a reduction of Firmicutes, such as Faecalibacterium praus-
nitzii, in CD (Manichanh et al., 2006; Kang et al., 2010). A 16S
rRNA gene pyrosequencing study of twin pairs who were con-
cordant or discordant for CD or UC showed a clear division in
the microbial composition between CD and healthy individu-
als but not between UC and healthy individuals (Willing et al.,
2010). There were more Firmicutes detected for colonic involve-
ment CD and less for ileum localized CD (ICD) compared to
healthy subjects. In addition to F. prausnitzii, also other core
members of the microbiota, such as Roseburia, were less abun-
dant in ICD. Interestingly, a separate study analyzing the same
samples showed clear shifts in metabolic profiles correspond-
ing to the same bacterial groups (Jansson et al., 2009). Pathways
with differentiating metabolites included those involved in the
metabolism and or synthesis of amino acids, fatty acids, bile acids,
and arachidonic acid.
A recent analysis of the fecal microbiota of UC patients in
relapse and remission further confirmed the reduction of bac-
terial diversity in these patients and showed that this mainly
affects members of the Clostridium cluster IV within the phy-
lum Firmicutes (Rajilic-Stojanovic et al., 2012). The authors also
speculated on the role of SCFA in UC as they reported reduced
numbers of butyrate-producing bacteria, along with other stud-
ies (Frank et al., 2007), and a disturbed abundance of typical
propionate producers. A depletion of one propionate producer,
A. muciniphila, was observed in the fecal samples while another
one,Megamonas sp. was increased. A. muciniphila was previously
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found to be decreased in biopsies of patients with UC with
an associated increase in Ruminococcus sp. (Png et al., 2010).
The role of butyrate and propionate, both of which have anti-
inflammatory properties (Tedelind et al., 2007), in UC is still
under debate (Chapman et al., 1994; Roediger et al., 1997). These
and forthcoming studies will eventually help in screening and
diagnosing IBD patients.
OBESITY AND METABOLIC SYNDROME
Obesity and obesity-associated metabolic disorders, such as
metabolic syndrome and type 2 diabetes have been suggested to
be associated with the composition and function of the intesti-
nal microbiota. Initial research showed an increase in the relative
abundance of Firmicutes and decrease in Bacteroidetes in both
obese mice (Ley et al., 2005) and humans (Ley et al., 2006), but
later studies have failed to endorse these findings and showed
inconsistent results with respect to the changes in the microbiota
of obese people (Nadal et al., 2009; Santacruz et al., 2009, 2010;
Zhang et al., 2009; Schwiertz et al., 2010) (Figure 1). In addition,
the transfer of the gut microbiota of obese (ob/ob) mice to germ-
free wild-typemice causes an increase in fat mass in the recipients,
indicating that the obese microbiota has an increased capacity to
harvest energy from the diet (Turnbaugh et al., 2006).
Departing from these findings, scientists are now trying to
unravel the mechanisms behind the observations. One study
found that loss of Toll-like receptor (TLR) 5, which is a trans-
membrane protein recognizing bacterial flagellin, in a mouse
model results in a phenotype resembling human metabolic syn-
drome (Vijay-Kumar et al., 2010). The authors speculated that
the loss of this receptor alters the microbiota inducing low-grade
inflammatory signalling, which eventually leads to hyperpha-
gia and metabolic syndrome. In another study, TLR 2-deficient
mice, which are protected from diet-induced insulin resistance
under germ-free settings, developed a condition reminiscent of
metabolic syndrome after colonization (Caricilli et al., 2011). The
microbiota of the mice showed notable increase in Firmicutes and
slight increase in Bacteroidetes compared to controls. The authors
suggested that the mechanisms by which the TLR 2-deficient
mice became insulin resistant and, later, obese could be related
to increased capacity for energy harvesting from the diet or alter-
natively to increased level of LPS caused by increased gut perme-
ability and LPS absorption. Recently, it was shown that antibiotic
treatment with vancomycin for diet-induced obese mice signif-
icantly reduced the proportions of Firmicutes and Bacteroidetes,
and increased Proteobacteria (Murphy et al., 2012). These changes
were associated with improvement in the metabolic abnormal-
ities associated with obesity, by reducing body weight gain
and improving inflammatory and metabolic health of the host.
Based on these studies, it seems plausible that the ability of
the gut microbiota to regulate inflammatory responses play an
important role in the complex mechanisms behind obesity and
metabolic syndrome. Still, more long-term studies in animal
models and humans are required to acquire a clearer picture of
the relationship between the intestinal microbiota and different
diseases.
CONCLUDING REMARKS
The complexity of the microbiota–host interactions has been
the prime obstacle in defining microbial functionality at a
post-genomic level. The recent technical advances in analyzing
genomes, transcriptomes and proteomes of complex bacterial
consortia and intra- and interspecies metabolic networks help to
tackle this problem and will enable systems-level analyses of the
crosstalk between the microbiota and the host.
There are multiple reports providing circumstantial evidence
to support the concept that microbiota composition and activ-
ity influence host metabolism and disease development. These
examples include the differences in microbiota composition and
microbiota expressed proteins of breastfeeding as compared to
formula-fed babies (Schwartz et al., 2012), differences between
microbiota composition and activity between healthy and mal-
nourished infants (Monira et al., 2011), differences in the micro-
biota composition of elderly and centenarians as compared to
youngsters (Biagi et al., 2010), and differences inmicrobiota com-
position and activity between humans that are either lean or obese
(Ley et al., 2005; Zhang et al., 2009) and healthy or suffering
of IBD (Willing et al., 2010). The data suggest that the activity
and composition of the microbiota is affected by food intake and
genetic background of the host. Most findings are supported by
animal studies but there is also data on human subjects. The field
of functional microbiomics is still rapidly advancing with contin-
uously emerging new techniques and results. Nevertheless, a lot
of times the high throughput techniques fail to correlate bacterial
species and genome content to function due to the lack of charac-
terized isolates and genes. It is important to identify the regulating
parameters of the functioning intestinal ecosystem to gain insight
into the influence of the microbiota on human development,
aging, and disease.
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